
Ozempic face (GLP-1) facial volume loss: 2026 review
Why GLP-1 receptor agonists cause facial volume loss, severity predictors, and the published multimodal restoration approaches in 2026.
The DermatologyNews editorial team researches, writes, and fact-checks all articles against peer-reviewed literature and society guidance. Every article is medically reviewed by a board-certified dermatologist before publication.

Why GLP-1 receptor agonists cause facial volume loss, severity predictors, and the published multimodal restoration approaches in 2026.

What polynucleotide injectables do, what the systematic review data shows, how they compare with HA boosters, adverse events, and patient selection.

Mechanism of collagen induction, expected timeline, reconstitution evidence, recognized complications, and patient selection for PLLA.

Mechanism, timeline, comparator data vs MFU-V, adverse events, and patient selection for monopolar radiofrequency facial tightening.
Mechanism, timeline, comparator data, adverse events, and patient selection for microfocused ultrasound — based on published clinical trials and reviews.
Evidence for FDA-approved hydroquinone + tretinoin + fluocinolone for melasma — efficacy vs monotherapy, adverse effects, and adjunctive options.
What patients should ask and clinicians should disclose before MFU-V, radiofrequency, or combination skin tightening — checklist + red flags.